HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The roles of IGF2 and DNMT methylation and elongase6 related fatty acids in metabolic syndrome.

Abstract
Background: The prevalence of metabolic syndrome (MetS) has increased along with rapid socio-economic development in China in recent decades, aggravating the burden of the health care system. Both plasma levels of fatty acids (FAs) and aberrant DNA methylation profiles are associated with MetS risk. However, studies exploring the role of DNA methylation and FAs simultaneously in MetS etiology are sparse. Objective: We aimed to explore the association between the gene methylation levels of insulin-like growth factor II (IGF2), H19, DNA methyltransferases 1 (DNMT1), DNA methyltransferases 3a (DNMT3a), and DNA methyltransferases 3b (DNMT3b) and MetS risk, and the etiological role of elongation of very-long-chain fatty acid elongase 6 (ELOVL6) related fatty acids. Method: Plasma levels of FAs were measured using a Gas Chromatography-Flame Ionization Detector (GC-FID) after organic extraction, and gene methylation was quantified using a real-time Quantitative Polymerase Chain Reaction (Q-PCR) detecting system after bisulfite treatment. The C18/C16 ratio was used as the indicator of ELOVL6 activity. Odds Ratio (OR) and 95% Confidence Interval (CI) were estimated with logistic regression. Results: Methylation levels in IGF2 and DNMT3a were not significantly associated with MetS risk. However, when stratified by C18/C16 ratio (high vs. low), positive associations were observed between the risk of MetS and methylation levels (>median) of IGF2a3 (OR = 3.1, 95% CI = 1.3-7.5) and DNMT3a (OR = 2.5, 95% CI = 1.1-5.8) genes, in individuals with lower C18/C16 ratios, while no significant associations were observed in subjects with high C18/C16 ratios. Conclusion: Methylation levels in IGF2 and DNMT3a genes may affect the risk of MetS in an ELOVL6 activity-dependent way among Chinese adults. Further studies in other populations are needed to validate this finding.
AuthorsXiang Li, Chen Lyu, ZhongCheng Luo, Jing Zhao, Zhongli Wang, Chun Yang, Qi Dai, Hui Li, Yunhua Zhou, Zi Li, Fuxue Chen, Ying Gao
JournalFood & function (Food Funct) Vol. 12 Issue 20 Pg. 10253-10262 (Oct 19 2021) ISSN: 2042-650X [Electronic] England
PMID34549217 (Publication Type: Journal Article)
Chemical References
  • Fatty Acids
  • IGF2 protein, human
  • Insulin-Like Growth Factor II
  • DNA (Cytosine-5-)-Methyltransferase 1
  • DNA (Cytosine-5-)-Methyltransferases
  • Fatty Acid Elongases
Topics
  • Adult
  • China (epidemiology)
  • DNA (Cytosine-5-)-Methyltransferase 1 (metabolism)
  • DNA (Cytosine-5-)-Methyltransferases (metabolism)
  • DNA Methylation
  • Fatty Acid Elongases (blood)
  • Fatty Acids (blood, metabolism)
  • Female
  • Humans
  • Insulin-Like Growth Factor II (metabolism)
  • Logistic Models
  • Male
  • Metabolic Syndrome (blood, epidemiology, metabolism)
  • Middle Aged
  • Prevalence
  • Risk Factors
  • DNA Methyltransferase 3B

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: